Eylea
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
PURPOSE
To investigate the effect of age on aflibercept (Eylea) response in macular edema secondary to treatment-naive diabetic…
Purpose: Aflibercept (Eylea™, Regeneron) is supplied in single-use glass vials along with 1 cc polycarbonate syringes. We sought…
Vascular endothelial growth factor (VEGF) is a key mediator in the development and progression of choroidal neovascularization…
PurposeTo investigate the short-term effect of single intravitreal aflibercept injection on retrobulbar blood flow in patients…
Aflibercept (Eylea®) is a fully human, recombinant fusion protein available in various countries worldwide, including those of…
PURPOSE
We determined the intraocular pharmacokinetic properties of intravitreally injected aflibercept (Eylea) in a rabbit model…
Background: We present an interesting case of bilateral retinitis pigmentosa (RP)-associated cystoid macular oedema that…
Aflibercept is a fully human, recombinant fusion protein that acts as a soluble decoy receptor for vascular endothelial growth…
Purpose OPT‐302 is a soluble receptor that specifically and potently blocks VEGF‐C and VEGF‐D activity which are involved in the…